A0A140VJR0 (A0A140VJR0_HUMAN) Homo sapiens (Human)
Phosphodiesterase UniProtKBInterProInteractive Modelling
809 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: Q08499
It is possible new templates exist for this target since these models were created.
Available Structures
112 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| crystal structure of PDE4D catalytic domain and zardaverine complex | homo-6-mer | 99.69 | 6×ZN; 6×MG; 6×ZAR; | |||
| PDE4 complexed with inhibitor | homo-4-mer | 100.0 | 4×3KQ; 4×ZN; 4×MG; | |||
| Crystal structure of PDE4D2 in complex with inhibitor LEO39652 | homo-4-mer | 100 | 4×QDT; 28×EDO; 4×DMS; 4×MG; 4×ZN; | |||
| Crystal structure of PDE4D in complex with L-869298 | homo-4-mer | 100 | 4×ZN; 4×MG; 4×M98; | |||
| Crystal structure of PDE4D2 in complex with (R,S)-rolipram | homo-4-mer | 100 | 8×ZN; 4×ROL; | |||
| Crystal structure of PDE4D2 in complex with inhibitor L-869299 | homo-4-mer | 100 | 4×ZN; 4×MG; 4×M99; | |||
| Structure of PDE4D2-IBMX | homo-4-mer | 100 | 4×ZN; 4×MG; 4×IBM; | |||
| The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysis | homo-4-mer | 100 | 8×ZN; 4×AMP; | |||
| Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor select… | homo-4-mer | 100 | 8×ZN; 4×ROL; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-42a | homo-2-mer | 100 | 2×ZN; 8×MG; 28×EDO; 2×T3K; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-41b | homo-2-mer | 100 | 2×S8Q; 2×ZN; 8×MG; 14×EDO; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-18a | homo-2-mer | 100 | 2×ZN; 5×MG; 2×D0E; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-32a | homo-2-mer | 100 | 2×ZN; 5×MG; 2×EDO; 1×DD5; 1×D5N; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-4a | homo-2-mer | 100 | 2×ZN; 5×MG; 2×CZT; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-7b | homo-2-mer | 100 | 3×MG; 2×ZN; 2×CV8; 2×GOL; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-18b | homo-2-mer | 100 | 2×ZN; 4×MG; 2×D0B; | |||
| Crystal structure of PDE4D catalytic domain in complex with arctigenin | homo-2-mer | 100 | 2×ZN; 2×MG; 2×EQC; 26×EDO; | |||
| Structure of the PDE4D-cAMP complex | homo-2-mer | 99.69 | 2×ZN; 2×CMP; | |||
| Crystal structure of PDE4D2 in complex with inhibitor NPV | homo-2-mer | 100 | 2×NPV; 2×ZN; 2×MG; | |||
| Crystal structure of PDE4D catalytic domain in complex with Apremilast | homo-2-mer | 100 | 3×MG; 2×ZN; 11×EDO; 2×A9L; | |||
| The structure of the catalytic domain of human PDE4d with 4-(3-Butoxy-4-methoxyphenyl)methyl-2-imid… | homo-2-mer | 100 | 2×ZN; 2×0MO; 2×MG; | |||
| Crystal structure of PDE4D catalytic domain complexed with compound 21d | homo-2-mer | 100 | 2×ZN; 2×MG; 2×AQL; | |||
| Crystal structure of PDE4D catalytic domain in complex with compound 36 | homo-2-mer | 100 | 2×ZN; 2×MG; 2×FTX; 12×EDO; | |||
| Crystal structure of PDE4D complexed with benzbromarone | homo-2-mer | 100 | 2×ZN; 2×MG; 2×R75; 2×EDO; | |||
| Crystal structure of PDE4D complexed with ethaverine hydrochloride | homo-2-mer | 100 | 2×VIC; 2×MG; 2×ZN; 1×EDO; | |||
| The crystal structure of PDE4D with Amentoflavone | homo-2-mer | 100 | 2×ZN; 2×MG; 2×A1D6Q; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 3×MG; 2×ZN; 2×AH6; 11×EDO; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×ZN; 4×MG; 2×AH9; 11×EDO; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×ZN; 2×MG; 2×AJX; 14×EDO; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×ZN; 4×MG; 2×AH3; 13×EDO; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×AKO; 3×MG; 2×ZN; 5×EDO; | |||
| PDE4D complexed with inhibitor | homo-2-mer | 100.0 | 2×3GJ; 4×ZN; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×ZN; 2×MG; 10×EDO; 2×AK0; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×ZN; 4×MG; 2×AH9; 15×EDO; | |||
| Crystal structure of PDE4D complexed with CX-4945 | homo-2-mer | 100 | 2×MG; 2×ZN; 2×3NG; 6×EDO; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×ZN; 3×MG; 2×AJL; 12×EDO; | |||
| Crystal structure of PDE4D complexed with 7b-1 | homo-2-mer | 100 | 2×MG; 2×ZN; 2×W8E; 4×EDO; | |||
| Crystal structure of PDE4D complexed with DCN | homo-2-mer | 100 | 2×MG; 2×ZN; 2×W8O; 3×EDO; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×ZN; 2×MG; 2×AKU; 4×EDO; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-26g | homo-2-mer | 100 | 2×ZN; 4×MG; 2×D08; 2×EDO; 1×DMS; | |||
| PDE4D crystal structure in complex with small molecule inhibitor | homo-2-mer | 100.0 | 2×ZN; 2×MG; 2×6Q2; 32×EDO; | |||
| Crystal structure of PDE4D complexed with a novel inhibitor | homo-2-mer | 100 | 2×ZN; 2×MG; 2×AKU; 1×EDO; | |||
| Crystal structure of human phosphodiesterase 4d (PDE4d) with papaverine. | homo-2-mer | 100 | 2×ZN; 2×MG; 2×EV1; | |||
| Crystal structure of PDE4D complexed with CVT-313 | homo-2-mer | 100 | 2×AJR; 2×MG; 2×ZN; 8×EDO; | |||
| Crystal structure of PDE4D complexed with glycyrrhisoflavone | homo-2-mer | 100 | 2×ZN; 2×MG; 2×JN0; 5×EDO; | |||
| Crystal structure of PDE4D complexed with licoisoflavone A | homo-2-mer | 100 | 2×ZN; 2×MG; 2×JU3; 5×EDO; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-54 | homo-2-mer | 100 | 2×CZK; 4×MG; 2×ZN; 1×EDO; | |||
| Crystal structure of PDE4D catalytic domain complexed with compound 22d | homo-2-mer | 100 | 2×ZN; 2×MG; 2×AWI; | |||
| Crystal structure of the PDE4D catalytic domain in complex with GEBR-20b | homo-2-mer | 100 | 2×ZN; 5×MG; 3×CZQ; | |||
| Crystal structure of PDE4D catalytic domain complexed with compound 23a | homo-2-mer | 100 | 2×ZN; 2×MG; 2×B6V; | |||
| Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-48 | monomer | 100.0 | 1×ZN; 2×MG; 1×KRD; | |||
| Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN14770 | monomer | 100.0 | 2×ZN; 1×MG; 1×KR7; 1×BTB; 1×SO4; 1×EDO; | |||
| Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-49 | monomer | 100.0 | 1×ZN; 1×MG; 1×KR4; | |||
| Crystal structure of human phosphodiesterase 4D with bound allosteric modulator | monomer | 100.0 | 1×15X; 1×ZN; 1×MG; 1×EPE; | |||
| Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871 | monomer | 100.0 | 1×ZN; 1×MG; 1×CA; 1×D71; | |||
| Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004 | monomer | 100.0 | 2×ZN; 1×MG; 1×E31; 1×CL; | |||
| Crystal structure of human phosphodiesterase 4d with d155988/pmnpq | monomer | 100 | 1×ZN; 1×MG; 1×SO4; 1×988; 4×EDO; | |||
| Crystal structure of PDE4D catalytic domain complexed with Selaginpulvilins K | monomer | 100 | 1×J20; 1×ZN; 1×MG; | |||
| Crystal structure of human phosphodiesterase 4d with d155871 | monomer | 100 | 1×ZN; 1×MG; 1×SO4; 1×D71; 3×EOH; | |||
| Crystal structure of the catalytic domain of PDE4D2 with (S)-N-(3-{1-[1-(3-Cyclopropylmethoxy-4-dif… | monomer | 100 | 1×IHM; 2×ZN; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-048 | monomer | 100 | 1×ZN; 1×MG; 13×EDO; 1×EPE; 1×E6Z; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-617 | monomer | 100 | 1×ZN; 2×MG; 1×QWT; 15×EDO; 1×PEG; 5×DMS; 1×EPE; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-769 | monomer | 100 | 1×ZN; 1×MG; 19×EDO; 1×J2E; 1×EPE; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-226 | monomer | 100 | 1×ZN; 1×MG; 21×EDO; 1×PEG; 1×D5T; | |||
| Crystal structure of human phosphodiesterase 4d with rolipram | monomer | 100 | 1×ZN; 1×MG; 1×SO4; 1×ROL; 8×EDO; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356 | monomer | 100 | 1×ZN; 1×MG; 15×EDO; 6×PEG; 1×D62; 1×EPE; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-656 | monomer | 100 | 1×ZN; 1×MG; 10×EDO; 1×QWZ; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-001 | monomer | 100 | 1×ZN; 1×MG; 8×EDO; 2×DTT; 1×6M5; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-768 | monomer | 100 | 1×ZN; 1×MG; 7×EDO; 1×EPE; 1×RLW; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-007 | monomer | 100 | 1×ZN; 1×MG; 20×EDO; 1×PEG; 1×EPE; 1×E8H; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1439 | monomer | 100 | 1×ZN; 1×MG; 19×EDO; 1×PEG; 1×D68; 1×EPE; 1×NI; | |||
| Crystal structure of the catalytic domain of PDE4D2 with compound 10D | monomer | 100 | 2×ZN; 16×EDO; 2×DMS; 1×PEG; 1×PO4; 1×JN4; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-637 | monomer | 100 | 1×ZN; 1×MG; 10×EDO; 1×E3Q; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-053 | monomer | 100 | 1×ZN; 1×MG; 12×EDO; 1×PEG; 1×DTT; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-425 | monomer | 100 | 1×ZN; 1×MG; 9×EDO; 1×E6E; 1×EPE; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1361 | monomer | 100 | 1×ZN; 1×MG; 13×EDO; 1×DMS; 1×863; 1×EPE; | |||
| CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH A TETRAFLUORANLINE COMPOUND | monomer | 100.0 | 1×ZN; 1×MG; 1×SO4; 3×EOH; 1×7DJ; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-635 | monomer | 100 | 1×ZN; 1×MG; 9×EDO; 1×EPE; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-654 | monomer | 100 | 1×ZN; 1×MG; 9×EDO; 1×EPE; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-417 | monomer | 100 | 1×ZN; 1×MG; 9×EDO; 1×EPE; 1×4I7; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-3098 | monomer | 100 | 1×ZN; 1×MG; 7×EDO; 1×E6N; 1×EPE; | |||
| Crystal structure of human phosphodiesterase 4d with roflumilast | monomer | 100.0 | 1×ZN; 1×MG; 1×SO4; 1×ROF; 3×EDO; | |||
| Crystal structure of the catalytic domain of PDE4D2 with compound 2 | monomer | 100 | 1×2SR; 8×EDO; 1×PEG; 2×ZN; 2×DMS; | |||
| Crystal structure of the catalytic domain of PDE4D2 complexed with compound 10d | monomer | 100 | 2×ZN; 1×J25; 2×EDO; 1×DMS; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1335 | monomer | 100 | 15×EDO; 2×PEG; 1×ZN; 1×FFZ; 1×MG; 1×EPE; | |||
| Crystal structure of the apo form of the catalytic domain of PDE4D2 | monomer | 100 | 17×EDO; 1×PEG; 2×ZN; 1×PO4; | |||
| Crystal structure of PDE4D catalytic domain complexed with compound 1 | monomer | 100 | 1×ZN; 1×MG; 1×MKU; | |||
| Crystal structure of the catalytic domain of PDE4D2 with compound 12c | monomer | 100 | 2×ZN; 9×EDO; 1×JN8; | |||
| Crystal structure of the catalytic domain of PDE4D2 with compound 10o | monomer | 100 | 13×EDO; 2×ZN; 1×PEG; 1×JN7; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p… | monomer | 100 | 1×ZN; 1×MG; 1×7DE; 18×EDO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1H-pyrazole-4-carboxyli… | monomer | 100 | 1×ZN; 1×MG; 1×DEE; 11×EDO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Cilomilast | monomer | 100 | 1×ZN; 1×MG; 1×CIO; 9×EDO; | |||
| Crystal structure of PDE4D2 in complex with inhibitor (S_Zl-n-91) | monomer | 100 | 1×AKJ; 1×ZN; 2×MG; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-phenyl-1H-pyrazole-4-… | monomer | 100 | 1×ZN; 1×MG; 1×3DE; 10×EDO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-methoxy-phenyl)-3,5-dimethyl-1H… | monomer | 100 | 1×ZN; 1×MG; 1×4DE; 12×EDO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Piclamilast | monomer | 100.0 | 1×ZN; 1×MG; 1×PIL; 1×B3P; 20×EDO; | |||
| Crystal structure of the PDE4D2 catalytic domain in complex with inhibitor (R)-Zl-n-91 | monomer | 100 | 1×R91; 1×ZN; 2×MG; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Roflumilast | monomer | 100 | 1×ZN; 1×MG; 12×EDO; 1×ROF; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-amino-phenyl)-3,5-dimethyl-1H-p… | monomer | 100 | 1×ZN; 1×MG; 1×5DE; 8×EDO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With AMP | monomer | 100.0 | 1×ZN; 1×MG; 1×AMP; 14×EDO; 1×B3P; | |||
| Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1086 | monomer | 100 | 11×EDO; 2×D5Z; 1×MG; 1×ZN; 1×EPE; | |||
| Crystal structure of PDE4D catalytic domain complexed with compound 18d | monomer | 100 | 1×ZN; 1×MG; 1×1GF; | |||
| Crystal structure of the PDE4D catalytic domain in complex with osthole | monomer | 100 | 2×ZN; 1×A0O; | |||
| PDE4 crystal structure in complex with small molecule inhibitor | monomer | 100.0 | 1×6PT; 1×ZN; 1×MG; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Zardaverine | monomer | 100.0 | 1×ZN; 1×MG; 1×ZAR; | |||
| Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Rolipram | monomer | 100.0 | 1×ZN; 1×MG; 1×ROL; 5×EDO; | |||
| Crystal structure of PDE4D catalytic domain complexed with 33a | monomer | 100 | 1×ZN; 1×MG; 1×8GO; | |||
| Crystal structure of PDE4D catalytic domain complexed with 17 | monomer | 100 | 1×ZN; 1×MG; 1×8G7; | |||
| Crystal structure of PDE4D catalytic domain complexed with compound 4e | monomer | 100 | 1×M36; 1×ZN; 1×MG; | |||
| Crystal structure of PDE4D catalytic domain complexed with compound 17a | monomer | 100 | 1×ZN; 1×MG; 1×0X8; | |||
| Crystal structure of PDE4D catalytic domain complexed with compound 18a | monomer | 100 | 1×ZN; 1×MG; 1×1AS; | |||
| The structure of the RACK1 interaction sites located within the unique N-terminal region of the cAM… | monomer | 29.03 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4wzi.1.A | homo-2-mer | 0.76 | 2×ZN; | 79.22 | ||